SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,503.87 -105.21
(-0.99%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

38.79

766.2

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

Manbro Industries reports standalone net loss of Rs 0.05 crore in the September 2025 quarter

Nov 16,2025

Net Loss of Manbro Industries reported to Rs 0.05 crore in the quarter ended September 2025 as against net loss of Rs 0.14 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 1.23 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0	1.23	-100
OPM %	0	-11.38	-
PBDT	0.21	-0.14	LP
PBT	0.21	-0.14	LP
NP	-0.05	-0.14	64

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,503.87 -105.21 (-0.99%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)